CAH Logo

Cardinal Health, Inc. (CAH) 

NYSE
Market Cap
$29.84B
Sector
Healthcare
Industry
Medical—Distribution
Rank in Sector
345 of 774
Rank in Industry
3 of 8

Largest Insider Buys in Sector

CAH Stock Price History Chart

CAH Stock Performance

About Cardinal Health, Inc.

Cardinal Health, Inc. operates as an integrated healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home. The company operates in two segments, Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical, and over-the-counter healthcare and consumer …

Insider Activity of Cardinal Health, Inc.

Over the last 12 months, insiders at Cardinal Health, Inc. have bought $0 and sold $25.97M worth of Cardinal Health, Inc. stock.

On average, over the past 5 years, insiders at Cardinal Health, Inc. have bought $29,239 and sold $11.28M worth of stock each year.

There was no buying activity among insiders over the last 12 months.

The last purchase of 200 shares for transaction amount of $14,944 was made by Brennan Michelle (director) on 2022‑11‑15.

List of Insider Buy and Sell Transactions, Cardinal Health, Inc.

2024-11-14SaleChief Accounting Officer
3,504
0.0015%
$123.55$432,919-0.88%
2024-08-21SaleChief Legal/Compliance Officer
16,573
0.0068%
$109.39$1.81M+2.12%
2024-08-19SaleChief Executive Officer
46,455
0.0189%
$109.02$5.06M+1.99%
2024-08-19SaleCEO, GMPD Segment
46,998
0.0192%
$109.21$5.13M+1.99%
2024-08-19SaleChief Financial Officer
2,323
0.0009%
$108.91$252,998+1.99%
2024-08-19SaleChief Human Resources Officer
34,647
0.0141%
$109.00$3.78M+1.99%
2024-08-19SaleChief Information Officer
4,000
0.0016%
$108.85$435,400+1.99%
2024-08-16SaleChief Executive Officer
26,716
0.0119%
$108.87$2.91M0.00%
2024-08-16SaleChief Human Resources Officer
3,294
0.0015%
$108.00$355,7520.00%
2024-08-15SaleChief Legal/Compliance Officer
17,896
0.0078%
$106.48$1.91M0.00%
2023-11-27SaleCEO, Pharmaceutical Segment
36,642
0.0148%
$106.31$3.9M-0.61%
2023-08-28SaleCEO, Pharmaceutical Segment
6,712
0.0027%
$89.81$602,805+14.72%
2023-08-18SaleChief Accounting Officer
20,695
0.0082%
$86.27$1.79M+19.33%
2023-08-17SaleChief Legal/Compliance Officer
10,668
0.0043%
$87.68$935,370+18.49%
2023-08-17SaleCEO, Medical Segment
37,500
0.0149%
$87.32$3.27M+18.49%
2023-08-17SaleChief Human Resources Officer
26,324
0.0105%
$87.41$2.3M+18.49%
2023-08-17SaleChief Information Officer
2,000
0.0008%
$86.79$173,580+18.49%
2023-08-16SaleChief Legal/Compliance Officer
30,145
0.0119%
$90.84$2.74M+13.13%
2022-11-15Purchasedirector
200
<0.0001%
$74.72$14,944+15.15%
2022-11-14Purchasedirector
200
<0.0001%
$76.30$15,260+13.61%

Insider Historical Profitability

4.91%
Snow Ola MChief Human Resources Officer
27516
0.0114%
$123.2825
WALTER ROBERT Ddirector
937754
0.3875%
$123.28112+9.1%
CLARK R KERRYFormer Chairman and CEO
172680
0.0714%
$123.2810<0.0001%
FORD BRENDAN AEVP-Corporate Development
87052
0.036%
$123.2814+25.18%
FOTIADES GEORGE LPresident & COO
80400
0.0332%
$123.2862<0.0001%

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
The Vanguard Group$3.43B12.5730.62M-2.06%-$72.26M0.06
BlackRock$3.06B11.2227.34M+4.76%+$139.05M0.07
State Street$1.59B5.7914.11M-2.75%-$44.84M0.07
Fidelity Investments$648.59M2.385.8M+7.13%+$43.15M0.04
Geode Capital Management$622.18M2.295.57M+2.37%+$14.43M0.05
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.